FindTrial
Sign In

A clinical trial to study the effect of three different doses of cisatracurium,a muscle relaxant i.e.0.1 mg/kg,0.2mg/kg and 0.3mg/kg on intubating conditions in the patients having surgery in general anesthesia

A study to compare three different doses of cisatracurium for intubating conditions in patients undergoing surgery in general anesthesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/016873
Enrollment
150
Registered
2019-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Comparing different doses of cisatracurium i.e. 0.1mg/kg, 0.2mg/kg, 0.3mg/kg for intubating conditions.: Comparing three different doses i.e. 0.1mg/kg, 0.2mg/kg or 0.3mg/kg for intubati

Sponsors

Department of Anaesthesiology Pt BD Sharma PGIMS Rohtak Haryana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologist (ASA) Physical Status I-II scheduled for surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: Patients with cardiovascular, hepatic, renal or neuromuscular disorders. Pregnant or lactating women. Patients with airway problems suggesting difficult intubation. Patients receiving drugs known to interact with neuromuscular blocking agents. Patients allergic to the drug used in the study.

Design outcomes

Primary

MeasureTime frame
Time of onset of cisatracurium Intubating conditions Recovery time of cisatracurium Signs of histamine releaseTimepoint: Every 12 seconds—

Secondary

MeasureTime frame
Hemodynamic monitoringTimepoint: Till 30 minutes—

Countries

India

Contacts

Public ContactJyoti Vats

PGIMS Rohtak

prashantkumarz@yahoo.com9416336901

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026